Skip to main content
BRNS logo

BRNS · Barinthus Biotherapeutics plc.

$0.57 -0.03 (-5.16%) At close · Jul 28
Market Cap
$23.28M
Shares
40.85M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 14
Total Value: $5,403,238
Total Shares: 9,297,185

Institutional Ownership Trend

21 quarters

Holder Concentration

Across 14 13F filers
Top Holder
55.9%
Jun 2023 → Mar 2026 · range 52.4% – 65.8%
of institutional value
Top 5
93.2%
Jun 2023 → Mar 2026 · range 93.2% – 97.0%
of institutional value
Top 10
99.3%
Jun 2023 → Mar 2026 · range 99.2% – 99.8%
of institutional value
HHI
3,596
Jun 2023 → Mar 2026 · range 3,268 – 4,727
Highly concentrated
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1828185 CUSIP 91864C107 13F (30d) 1 filings 1 filers Visit website